US Lawyer Database

Section 689.532 – Complimentary samples.

A practitioner who receives a complimentary sample of a controlled substance as defined in ORS 475.005 shall keep the sample in a securely locked, substantially constructed cabinet and shall maintain a record of receipts and withdrawals from each inventory of samples. Each licensing board that has jurisdiction over a practitioner’s license shall specify the recording […]

Section 689.555 – Agricultural drugs and certain other substances.

(1) Nothing in this chapter prohibits the sale by any person of agricultural or garden spray, sheep dip, blue stone, copperas, squirrel poison, fly paper, ant poison, gopher poison, insect powder, poultry vermifuge and arsenic sprays when they are in original unbroken packages, prepared and labeled with official poison labels and showing antidotes. (2) Nothing […]

Section 689.561 – Prescription readers; compatible labels; exception; rules.

(1) As used in this section: (a) “Person who is blind” means a person who is: (A) Visually impaired; (B) Print disabled; or (C) A person who is blind as that term is defined in ORS 346.510. (b) “Prescription reader” means a device that is designed to audibly convey the information contained on the label […]

Section 689.505 – Labeling requirements; rules.

(1)(a) Except as specifically provided by law and in compliance with ORS 689.564, a person may not distribute or dispense any drug without affixing to the authorized container a clear and legible label, either printed or written, bearing the name of the drug and the name and place of business of the person distributing or […]

Section 689.508 – Prescription records.

The original record of every prescription filled by a pharmacy must be kept on file for three years at the pharmacy or as specified by State Board of Pharmacy rule. The prescription record must contain the date of the transaction and the brand name, or if the drug has no brand name, the generic name […]

Section 689.515 – Regulation of generic drugs; substitutions; rules.

(1) As used in this section unless the context requires otherwise: (a) “Brand name” means the proprietary or trade name selected by the manufacturer and placed upon a drug, its container, label or wrapping at the time of packaging. (b) “Dosage form” means the physical formulation or medium in which the product is intended, manufactured […]

Section 689.524 – Approval of coverage for biological product.

ORS 689.522 does not prohibit an insurer or other health care payer from requiring prior authorization or imposing other appropriate utilization controls in approving coverage for any biological product. [2016 c.43 §4] Note: 689.524 was enacted into law by the Legislative Assembly but was not added to or made a part of ORS chapter 689 […]